Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Interim evaluation of the Rational Pharmacotherapy (GGG-) Programme

Publication date: 22 Dezember 2017 | Report language: EN

In the quest to improve healthcare, new and innovative medicines garner a lot of attention, but making better use of existing medicines is just as important. This can, for instance, mean understanding better which patients benefit from a particular treatment or tackling problems with adherence to medication. This field is known as rational pharmacotherapy.

In 2010, the Netherlands based Organisation for Health Research (ZonMw) prepared a report for the ministry of VWS on identified knowledge gaps in the field of rational pharmacotherapy. In response, the ministry commissioned ZonMw to set up the Rational Pharmacotherapy programme, known in Dutch as the programme ‘Goed Gebruik Geneesmiddelen (GGG)’. The programme was launched in 2012 to better understand and promote rational pharmacotherapy in practice. Up to May 2017, the programme has allocated €45.5m.

In 2017, five years after the launch of the programme, ZonMw commissioned the Technopolis Group to conduct an external interim evaluation, covering 2012 until mid-2017. The purpose of this evaluation was to assess the efficiency and effectiveness of the GGG-programme. The evaluation drew upon primary and secondary programme level data, (group) interviews, a survey among project leaders, and a review of selected projects. An independent committee of experts supported the evaluation process by interpreting and contextualising findings and by formulating conclusions and recommendations. The evaluation is presented in this underlying report by Technopolis Group